
Pharmavite takes women’s health portfolio to next level with Bonafide Health acquisition
“This acquisition positions us as the nation’s leading women’s health nutraceutical company,” said Jeff Boutelle, CEO of Pharmavite, following Pharmavite’s $425 Million deal for Bonafide Health.